 | • レポートコード：GIR-2104Z07444 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メシル酸イマチニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メシル酸イマチニブの種類別市場規模（99％純度、98％純度、その他）、用途別市場規模（CML、GIST、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メシル酸イマチニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GLEEVEC、Cayman Chemical、Sichuan Xieli、Nanjing Kaihua Chemical、Zhengda Tianqing ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：99％純度、98％純度、その他 ・用途別分析2016年-2026年：CML、GIST、その他 ・メシル酸イマチニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メシル酸イマチニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メシル酸イマチニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メシル酸イマチニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メシル酸イマチニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Imatinib Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Imatinib Mesylate size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Imatinib Mesylate market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Imatinib Mesylate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
99% Purity
98% Purity
Other
Market segment by Application can be divided into
CML
GIST
Other
The key market players for global Imatinib Mesylate market are listed below:
GLEEVEC
Cayman Chemical
Sichuan Xieli
Nanjing Kaihua Chemical
Zhengda Tianqing
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Imatinib Mesylate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Mesylate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 99% Purity
1.2.3 98% Purity
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Mesylate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CML
1.3.3 GIST
1.3.4 Other
1.4 Global Imatinib Mesylate Market Size & Forecast
1.4.1 Global Imatinib Mesylate Sales in Value (2016-2026))
1.4.2 Global Imatinib Mesylate Sales in Volume (2016-2026)
1.4.3 Global Imatinib Mesylate Price by Type (2016-2026) & (USD/MT)
1.5 Global Imatinib Mesylate Production Capacity Analysis
1.5.1 Global Imatinib Mesylate Total Production Capacity (2016-2026)
1.5.2 Global Imatinib Mesylate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imatinib Mesylate Market Drivers
1.6.2 Imatinib Mesylate Market Restraints
1.6.3 Imatinib Mesylate Trends Analysis
2 Manufacturers Profiles
2.1 GLEEVEC
2.1.1 GLEEVEC Details
2.1.2 GLEEVEC Major Business
2.1.3 GLEEVEC Imatinib Mesylate Product and Services
2.1.4 GLEEVEC Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cayman Chemical
2.2.1 Cayman Chemical Details
2.2.2 Cayman Chemical Major Business
2.2.3 Cayman Chemical Imatinib Mesylate Product and Services
2.2.4 Cayman Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sichuan Xieli
2.3.1 Sichuan Xieli Details
2.3.2 Sichuan Xieli Major Business
2.3.3 Sichuan Xieli Imatinib Mesylate Product and Services
2.3.4 Sichuan Xieli Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Nanjing Kaihua Chemical
2.4.1 Nanjing Kaihua Chemical Details
2.4.2 Nanjing Kaihua Chemical Major Business
2.4.3 Nanjing Kaihua Chemical Imatinib Mesylate Product and Services
2.4.4 Nanjing Kaihua Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Zhengda Tianqing
2.5.1 Zhengda Tianqing Details
2.5.2 Zhengda Tianqing Major Business
2.5.3 Zhengda Tianqing Imatinib Mesylate Product and Services
2.5.4 Zhengda Tianqing Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Imatinib Mesylate Sales by Manufacturer
3.1 Global Imatinib Mesylate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Imatinib Mesylate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Imatinib Mesylate
3.4 Market Concentration Rate
3.4.1 Top 3 Imatinib Mesylate Manufacturer Market Share
3.4.2 Top 6 Imatinib Mesylate Manufacturer Market Share
3.5 Global Imatinib Mesylate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Imatinib Mesylate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imatinib Mesylate Market Size by Region
4.1.1 Global Imatinib Mesylate Sales in Volume by Region (2016-2026)
4.1.2 Global Imatinib Mesylate Revenue by Region (2016-2026)
4.2 North America Imatinib Mesylate Revenue (2016-2026)
4.3 Europe Imatinib Mesylate Revenue (2016-2026)
4.4 Asia-Pacific Imatinib Mesylate Revenue (2016-2026)
4.5 South America Imatinib Mesylate Revenue (2016-2026)
4.6 Middle East and Africa Imatinib Mesylate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Imatinib Mesylate Sales in Volume by Type (2016-2026)
5.2 Global Imatinib Mesylate Revenue by Type (2016-2026)
5.3 Global Imatinib Mesylate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Imatinib Mesylate Sales in Volume by Application (2016-2026)
6.2 Global Imatinib Mesylate Revenue by Application (2016-2026)
6.3 Global Imatinib Mesylate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Imatinib Mesylate Sales by Type (2016-2026)
7.2 North America Imatinib Mesylate Sales by Application (2016-2026)
7.3 North America Imatinib Mesylate Market Size by Country
7.3.1 North America Imatinib Mesylate Sales in Volume by Country (2016-2026)
7.3.2 North America Imatinib Mesylate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Imatinib Mesylate Sales by Type (2016-2026)
8.2 Europe Imatinib Mesylate Sales by Application (2016-2026)
8.3 Europe Imatinib Mesylate Market Size by Country
8.3.1 Europe Imatinib Mesylate Sales in Volume by Country (2016-2026)
8.3.2 Europe Imatinib Mesylate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Imatinib Mesylate Sales by Type (2016-2026)
9.2 Asia-Pacific Imatinib Mesylate Sales by Application (2016-2026)
9.3 Asia-Pacific Imatinib Mesylate Market Size by Region
9.3.1 Asia-Pacific Imatinib Mesylate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Imatinib Mesylate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Imatinib Mesylate Sales by Type (2016-2026)
10.2 South America Imatinib Mesylate Sales by Application (2016-2026)
10.3 South America Imatinib Mesylate Market Size by Country
10.3.1 South America Imatinib Mesylate Sales in Volume by Country (2016-2026)
10.3.2 South America Imatinib Mesylate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imatinib Mesylate Sales by Type (2016-2026)
11.2 Middle East & Africa Imatinib Mesylate Sales by Application (2016-2026)
11.3 Middle East & Africa Imatinib Mesylate Market Size by Country
11.3.1 Middle East & Africa Imatinib Mesylate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Imatinib Mesylate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Imatinib Mesylate Typical Distributors
12.3 Imatinib Mesylate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Imatinib Mesylate Revenue by Type, (USD Million), 2021-2026
Table 2. Global Imatinib Mesylate Revenue by Application, (USD Million), 2021-2026
Table 3. GLEEVEC Basic Information, Manufacturing Base and Competitors
Table 4. GLEEVEC Major Business
Table 5. GLEEVEC Imatinib Mesylate Product and Services
Table 6. GLEEVEC Imatinib Mesylate Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 8. Cayman Chemical Major Business
Table 9. Cayman Chemical Imatinib Mesylate Product and Services
Table 10. Cayman Chemical Imatinib Mesylate Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sichuan Xieli Basic Information, Manufacturing Base and Competitors
Table 12. Sichuan Xieli Major Business
Table 13. Sichuan Xieli Imatinib Mesylate Product and Services
Table 14. Sichuan Xieli Imatinib Mesylate Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nanjing Kaihua Chemical Basic Information, Manufacturing Base and Competitors
Table 16. Nanjing Kaihua Chemical Major Business
Table 17. Nanjing Kaihua Chemical Imatinib Mesylate Product and Services
Table 18. Nanjing Kaihua Chemical Imatinib Mesylate Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Zhengda Tianqing Basic Information, Manufacturing Base and Competitors
Table 20. Zhengda Tianqing Major Business
Table 21. Zhengda Tianqing Imatinib Mesylate Product and Services
Table 22. Zhengda Tianqing Imatinib Mesylate Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Imatinib Mesylate Sales by Manufacturer (2019-2021e) & (MT)
Table 24. Global Imatinib Mesylate Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Imatinib Mesylate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Imatinib Mesylate Production Capacity by Company, (MT): 2020 VS 2021
Table 27. Head Office and Imatinib Mesylate Production Site of Key Manufacturer
Table 28. Global Imatinib Mesylate Sales by Region (2016-2021e) & (MT)
Table 29. Global Imatinib Mesylate Sales by Region (2021-2026) & (MT)
Table 30. Global Imatinib Mesylate Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Imatinib Mesylate Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 33. Global Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 34. Global Imatinib Mesylate Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Imatinib Mesylate Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Imatinib Mesylate Price by Type (2016-2021e) & (USD/MT)
Table 37. Global Imatinib Mesylate Price by Type (2021-2026) & (USD/MT)
Table 38. Global Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 39. Global Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 40. Global Imatinib Mesylate Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Imatinib Mesylate Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Imatinib Mesylate Price by Application (2016-2021e) & (USD/MT)
Table 43. Global Imatinib Mesylate Price by Application (2021-2026) & (USD/MT)
Table 44. North America Imatinib Mesylate Sales by Country (2016-2021e) & (MT)
Table 45. North America Imatinib Mesylate Sales by Country (2021-2026) & (MT)
Table 46. North America Imatinib Mesylate Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Imatinib Mesylate Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 49. North America Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 50. North America Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 51. North America Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 52. Europe Imatinib Mesylate Sales by Country (2016-2021e) & (MT)
Table 53. Europe Imatinib Mesylate Sales by Country (2021-2026) & (MT)
Table 54. Europe Imatinib Mesylate Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Imatinib Mesylate Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 57. Europe Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 58. Europe Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 59. Europe Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 60. Asia-Pacific Imatinib Mesylate Sales by Region (2016-2021e) & (MT)
Table 61. Asia-Pacific Imatinib Mesylate Sales by Region (2021-2026) & (MT)
Table 62. Asia-Pacific Imatinib Mesylate Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Imatinib Mesylate Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 65. Asia-Pacific Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 66. Asia-Pacific Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 67. Asia-Pacific Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 68. South America Imatinib Mesylate Sales by Country (2016-2021e) & (MT)
Table 69. South America Imatinib Mesylate Sales by Country (2021-2026) & (MT)
Table 70. South America Imatinib Mesylate Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Imatinib Mesylate Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 73. South America Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 74. South America Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 75. South America Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 76. Middle East & Africa Imatinib Mesylate Sales by Country (2016-2021e) & (MT)
Table 77. Middle East & Africa Imatinib Mesylate Sales by Country (2021-2026) & (MT)
Table 78. Middle East & Africa Imatinib Mesylate Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Imatinib Mesylate Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Imatinib Mesylate Sales by Type (2016-2021e) & (MT)
Table 81. Middle East & Africa Imatinib Mesylate Sales by Type (2021-2026) & (MT)
Table 82. Middle East & Africa Imatinib Mesylate Sales by Application (2016-2021e) & (MT)
Table 83. Middle East & Africa Imatinib Mesylate Sales by Application (2021-2026) & (MT)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Imatinib Mesylate Typical Distributors
Table 87. Imatinib Mesylate Typical Customers
List of Figures
Figure 1. Imatinib Mesylate Picture
Figure 2. Global Imatinib Mesylate Sales Market Share by Type in 2020
Figure 3. 99% Purity
Figure 4. 98% Purity
Figure 5. Other
Figure 6. Global Imatinib Mesylate Sales Market Share by Application in 2020
Figure 7. CML
Figure 8. GIST
Figure 9. Other
Figure 10. Global Imatinib Mesylate Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Imatinib Mesylate Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Imatinib Mesylate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Imatinib Mesylate Sales (2016-2026) & (MT)
Figure 32. Global Imatinib Mesylate Production Capacity (2016-2026) & (MT)
Figure 33. Global Imatinib Mesylate Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Imatinib Mesylate Market Drivers
Figure 35. Imatinib Mesylate Market Restraints
Figure 36. Imatinib Mesylate Market Trends
Figure 37. Global Imatinib Mesylate Sales Market Share by Manufacturer in 2020
Figure 38. Global Imatinib Mesylate Revenue Market Share by Manufacturer in 2020
Figure 39. Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Imatinib Mesylate Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Imatinib Mesylate Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Imatinib Mesylate Sales Market Share by Region (2016-2026)
Figure 43. Global Imatinib Mesylate Revenue Market Share by Region (2016-2026)
Figure 44. North America Imatinib Mesylate Revenue (2016-2026) & (USD Million)
Figure 45. Europe Imatinib Mesylate Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Imatinib Mesylate Revenue (2016-2026) & (USD Million)
Figure 47. South America Imatinib Mesylate Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Imatinib Mesylate Revenue (2016-2026) & (USD Million)
Figure 49. Global Imatinib Mesylate Sales Market Share by Type (2016-2026)
Figure 50. Global Imatinib Mesylate Revenue Market Share by Type (2016-2026)
Figure 51. Global Imatinib Mesylate Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 53. Global Imatinib Mesylate Revenue Market Share by Application (2016-2026)
Figure 54. Global Imatinib Mesylate Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Imatinib Mesylate Sales Market Share by Country (2016-2026)
Figure 56. North America Imatinib Mesylate Revenue Market Share by Country (2016-2026)
Figure 57. North America Imatinib Mesylate Sales Market Share by Type (2016-2026)
Figure 58. North America Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 59. Europe Imatinib Mesylate Sales Market Share by Country (2016-2026)
Figure 60. Europe Imatinib Mesylate Revenue Market Share by Country (2016-2026)
Figure 61. Europe Imatinib Mesylate Sales Market Share by Type (2016-2026)
Figure 62. Europe Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Imatinib Mesylate Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Imatinib Mesylate Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Imatinib Mesylate Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 67. South America Imatinib Mesylate Sales Market Share by Country (2016-2026)
Figure 68. South America Imatinib Mesylate Revenue Market Share by Country (2016-2026)
Figure 69. South America Imatinib Mesylate Sales Market Share by Type (2016-2026)
Figure 70. South America Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Imatinib Mesylate Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Imatinib Mesylate Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Imatinib Mesylate Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Imatinib Mesylate Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のメシル酸イマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界のメシル酸ベンズトロピン市場 2021：企業別、地域別、種類・用途別 The Benztropine Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のイマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界のドキサゾシンメシレート市場 2021：企業別、地域別、種類・用途別 The Doxazosin Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の高純度ガス/超高純度ガス/純ガス市場 2021：企業別、地域別、種類・用途別 The High Purity Gas/Ultra High Purity Gas/Pure Gas market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…